Brevera™ Breast Biopsy System Data Collection Study

CompletedOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

November 20, 2017

Primary Completion Date

November 20, 2018

Study Completion Date

November 20, 2018

Conditions
Breast Cancer Female
Interventions
DEVICE

Brevera Breast Biopsy System

The Brevera Breast Biopsy System with CorLumina imaging technology is a vacuum-assisted biopsy device, which is used to remove breast tissue in a minimally invasive manner using stereotactic or tomosynthesis imaging. A breast biopsy is a test that removes tissue or sometimes fluid from the suspicious area. The removed cells are examined under a microscope and further tested to check for the presence of breast cancer. A biopsy is a diagnostic procedure that can definitely determine if the suspicious area is cancerous.

Trial Locations (6)

Unknown

Institut régional du Cancer de Montpellier, Montpellier

Brustdiagnostik Munchen, Tübingen

Radiologia Senologica, Milan

Noordwest Ziekenhuisgroep, Alkmaar

Centro de Patalogia de la Mama-Fundacion Tejerina, Madrid

Royal Free Londan NHS Foundation Trust, London

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Hologic, Inc.

INDUSTRY